Cargando…
The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis
BACKGROUND: Different genetic variants in hormone‐regulating pathways have been identified to influence the risk of breast cancer. This study aimed to evaluate the association of CYP19A1 rs10046 and rs700519 polymorphisms with the risk, clinicopathological factors and prognosis of breast cancer. MET...
Autores principales: | Alwan, Ahmad Mohammed, Afzaljavan, Fahimeh, Tavakol Afshari, Jalil, Homaei Shandiz, Fatemeh, Barati Bagherabad, Matineh, Vahednia, Elham, Kheradmand, Nahid, Pasdar, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372086/ https://www.ncbi.nlm.nih.gov/pubmed/34014013 http://dx.doi.org/10.1002/mgg3.1705 |
Ejemplares similares
-
Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran
por: Afzaljavan, Fahimeh, et al.
Publicado: (2023) -
The Dilemma of TP53 Codon 72 Polymorphism (rs1042522) and
Breast Cancer Risk: A Case-Control Study and Meta-Analysis
in The Iranian Population
por: Afzaljavan, Fahimeh, et al.
Publicado: (2020) -
GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients
por: Afzaljavan, Fahimeh, et al.
Publicado: (2021) -
Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population
por: TAJBAKHSH, Amir, et al.
Publicado: (2021) -
“p53 Polymorphism at Codon 72 and Breast Cancer” - Letter
por: Afzaljavan, Fahimeh, et al.
Publicado: (2017)